ישראל - עברית - Ministry of Health

neopharm ltd, israel - recombinant human parathyroid hormone - recombinant human parathyroid hormone 100 mcg - parathyroid hormone

ישראל - עברית - Ministry of Health

neopharm ltd, israel - recombinant human parathyroid hormone - recombinant human parathyroid hormone 25 mcg - parathyroid hormone

ישראל - עברית - Ministry of Health

neopharm ltd, israel - recombinant human parathyroid hormone - recombinant human parathyroid hormone 50 mcg - parathyroid hormone

ישראל - עברית - Ministry of Health

neopharm ltd, israel - recombinant human parathyroid hormone - recombinant human parathyroid hormone 75 mcg - parathyroid hormone

ישראל - עברית - Ministry of Health

ferring pharmaceuticals ltd - follicle stimulating hormone (fsh); luteinizing hormone - אבקה וממס להכנת תמיסה להזרקה - follicle stimulating hormone (fsh) 75 iu/vial; luteinizing hormone 75 iu/vial - gonadotropins - sterility in females with hypo or normogonadotropic ovarian insufficiency: stimulation of follicle growth. sterility in males with hypo or normogonadotropic hypogonadism.

ישראל - עברית - Ministry of Health

merck serono ltd - luteinizing hormone - אבקה להכנת תמיסה לזריקה - luteinizing hormone 75 iu/ml - gonadotropins - luveris in association with a follicle stimulating hormone (fsh) preparation is recommended for the stimulation of follicular development in women with severe lh and fsh deficiency. in clinical trials these patients were defined by an endogenous serum lh level < 1.2 iu/l.

ישראל - עברית - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

ישראל - עברית - Ministry of Health

ferring pharmaceuticals ltd - triptorelin as embonate - suspension for injection - triptorelin as embonate 3.75 mg ml - triptorelin - triptorelin - lowering of sexual hormones and treatment of advanced prostate cancer. central precocious puberty.

ישראל - עברית - Ministry of Health

ferring pharmaceuticals ltd - triptorelin as embonate - suspension for injection - triptorelin as embonate 11.25 mg - triptorelin - triptorelin - prostatic cancer and lowering of sexual hormones.

ישראל - עברית - Ministry of Health

novartis israel ltd - lapatinib as ditosylate monohydrate - טבליות מצופות פילם - lapatinib as ditosylate monohydrate 250 mg - protein kinase inhibitors - tykerb is indicated for the treatment of adult patients with breast cancer, whose tumours overexpress her2 (erbb2);• in combination with capecitabine for patients with advanced or metastatic disease with progression following prior therapy, which must have included anthracyclines and taxanes and therapy with trastuzumab in the metastatic setting (see section 5.1).• tykerb is indicated in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer that overexpresses the her2 receptor for whom hormonal therapy is indicated. tykerb in combination with an aromatase inhibitor has not been compared to a trastuzumab-containing chemotherapy regimen for the treatment of metastatic breast cancer.